Value of Early Surgery in Small Intestinal Crohn's Disease
10.3969/j.issn.1008-7125.2020.04.012
- VernacularTitle: 早期手术干预在小肠克罗恩病治疗中的价值
- Author:
Xiuxiu HAO
1
Author Information
1. Department of Gastrointestinal Surgery, School of Medicine, Shanghai Jiao Tong University
- Publication Type:Journal Article
- Keywords:
Crohn Disease;
Early Surgery;
Infliximab;
Therapy
- From:
Chinese Journal of Gastroenterology
2020;25(4):246-249
- CountryChina
- Language:Chinese
-
Abstract:
Crohn's disease (CD) is a gastrointestinal tract chronic inflammatory disease with an increasing incidence worldwide. Treatment of CD is focused on symptom control and healing the intestinal mucosa in order to improve the quality of life and prevent complications. The early use of anti-TNF agents such as infliximab in CD patients with high risk factors has become the main treatment of CD clinically. However, infliximab has its limitations, early surgery might benefit the patient more. This article reviewed the therapeutic value of early surgery in small intestinal CD.
